Next Article in Journal
An Admission-to-Discharge BNP Increase Is a Predictor of Six-Month All-Cause Death in ADHF Patients: Inferences from Multivariate Analysis Including Admission BNP and Various Clinical Measures of Congestion
Next Article in Special Issue
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Previous Article in Journal
An Age-Related Morphometric Profile of Skeletal Muscle in Healthy Untrained Women
Previous Article in Special Issue
Multiple Roles for B-Lymphocytes in Sjogren’s Syndrome
Open AccessArticle

B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes

Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA
Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA
Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Author to whom correspondence should be addressed.
Academic Editor: Bonnie N. Dittel
J. Clin. Med. 2016, 5(11), 98;
Received: 5 September 2016 / Revised: 24 October 2016 / Accepted: 3 November 2016 / Published: 8 November 2016
(This article belongs to the Special Issue B Cells in Autoimmunity)
B cells have been strongly implicated in the development of human type 1 diabetes and are required for disease in the NOD mouse model. These functions are dependent on B cell antigen receptor (BCR) specificity and expression of MHC, implicating linked autoantigen recognition and presentation to effector T cells. BCR-antigen affinity requirements for participation in disease are unclear. We hypothesized that BCR affinity for the autoantigen insulin differentially affects lymphocyte functionality, including tolerance modality and the ability to acquire and become activated in the diabetogenic environment. Using combined transgenic and retrogenic heavy and light chain to create multiple insulin-binding BCRs, we demonstrate that affinity for insulin is a critical determinant of the function of these autoreactive cells. We show that both BCR affinity for insulin and genetic background affect tolerance induction in immature B cells. We also find new evidence that may explain the enigmatic ability of B cells expressing 125 anti-insulin BCR to support development of TID in NOD mice despite a reported affinity beneath requirements for binding insulin at in vivo concentrations. We report that when expressed as an antigen receptor the affinity of 125 is much higher than determined by measurements of the soluble form. Finally, we show that in vivo acquisition of insulin requires both sufficient BCR affinity and permissive host/tissue environment. We propose that a confluence of BCR affinity, pancreas environment, and B cell tolerance-regulating genes in the NOD animal allows acquisition of insulin and autoimmunity. View Full-Text
Keywords: BCR; B cell antigen receptor; insulin; type 1 diabetes (T1D); non-obese diabetic mouse (NOD) BCR; B cell antigen receptor; insulin; type 1 diabetes (T1D); non-obese diabetic mouse (NOD)
Show Figures

Figure 1

MDPI and ACS Style

Packard, T.A.; Smith, M.J.; Conrad, F.J.; Johnson, S.A.; Getahun, A.; Lindsay, R.S.; Hinman, R.M.; Friedman, R.S.; Thomas, J.W.; Cambier, J.C. B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes. J. Clin. Med. 2016, 5, 98.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop